VRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Valeant Pharmaceuticals International Inc's quarterly cash and cash equivalents declined from Jun. 2013 ($2,539 Mil) to Sep. 2013 ($596 Mil) but then increased from Sep. 2013 ($596 Mil) to Dec. 2013 ($600 Mil).
Valeant Pharmaceuticals International Inc's annual cash and cash equivalents increased from Dec. 2011 ($164 Mil) to Dec. 2012 ($916 Mil) but then declined from Dec. 2012 ($916 Mil) to Dec. 2013 ($600 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Valeant Pharmaceuticals International Inc Annual Data
Valeant Pharmaceuticals International Inc Quarterly Data